{"gene":"KCNJ9","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":2002,"finding":"GIRK channels containing Kir3.2 (GIRK2) and Kir3.3 (GIRK3) subunits mediate the acute inhibitory (hyperpolarizing) effects of opioids on locus ceruleus neurons; Kir3.2/3.3 double knockout mice showed ~80% reduction in opioid-induced current, demonstrating that K(G) channels—not cAMP-dependent cation conductance—are the primary mediators of this effect.","method":"Electrophysiology (whole-cell patch clamp) in brain slices from Kir3.2 KO, Kir3.3 KO, and Kir3.2/3.3 double KO mice with pharmacological blockers","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with defined electrophysiological phenotype, replicated across multiple genotypes with pharmacological validation","pmids":["12040038"],"is_preprint":false},{"year":2000,"finding":"GIRK2 and GIRK3 co-assemble into functional heteromultimeric GIRK channels; these channels display ~5-fold lower sensitivity to Gβγ activation compared to GIRK1-containing channels, and GIRK2/GIRK3 complexes can be immunoprecipitated from transfected cells and purified from native brain tissue.","method":"Patch clamp electrophysiology in co-transfected CHO-K1 cells; co-immunoprecipitation from transfected cells and native brain tissue","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP from both heterologous and native tissue plus functional characterization with multiple channel combinations","pmids":["10956667"],"is_preprint":false},{"year":1999,"finding":"GIRK3 forms functional heteromultimeric channels with GIRK1 (Kir3.1) in CHO cells; the GIRK1/GIRK3 combination has nearly identical single-channel conductance, kinetics, and Gβγ sensitivity compared to GIRK1/GIRK2 and GIRK1/GIRK4 channels.","method":"Single-channel patch clamp electrophysiology in CHO cells expressing GIRK1/GIRK3 with Gβγ dose-response","journal":"The Journal of membrane biology","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro reconstitution in heterologous cells with single-channel analysis, single lab","pmids":["10341034"],"is_preprint":false},{"year":2010,"finding":"GABAB receptors form stable oligomeric complexes directly with GIRK channels containing GIRK3; BRET experiments in living cells showed direct interaction between GABAB receptors and GIRK1/GIRK3 heterotetramers, and these receptor-effector complexes also exist in vivo in cerebellar granule cells. Complex formation likely occurs in the ER/Golgi.","method":"Bioluminescence resonance energy transfer (BRET), co-immunoprecipitation, confocal and electron microscopy in HEK-293 cells and native brain tissue","journal":"The European journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (BRET, Co-IP, EM) in both heterologous and native tissue","pmids":["20846323"],"is_preprint":false},{"year":2010,"finding":"Kir3.3 (GIRK3) directly binds NCAM and TrkB via its C-terminal intracellular domain; TrkB co-expression increases Kir3.1/3.3 K+ currents in Xenopus oocytes, while NCAM co-expression reduces this enhancement. TrkB regulates plasma membrane localization of Kir3.3, and premature Kir3.3 expression reduces NCAM-induced neurite outgrowth in hippocampal neurons.","method":"Co-immunoprecipitation, surface biotinylation, Xenopus oocyte electrophysiology, immunocytochemistry, analysis of TrkB-deficient mice, neurite outgrowth assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods across heterologous systems and primary neurons with genetic validation in KO mice","pmids":["20610389"],"is_preprint":false},{"year":2003,"finding":"Kir3.3 (GIRK3) is sorted specifically to axons in a subset of large GABAergic interneurons in the hippocampal CA3 region, with high levels in axons running with the mossy fiber tract and in large synaptic terminals co-expressing the vesicular GABA transporter.","method":"Immunocytochemistry (light and electron microscopy), primary cultures from hippocampal subareas in rodent brain","journal":"Molecular and cellular neurosciences","confidence":"Medium","confidence_rationale":"Tier 3 — direct subcellular localization by immunocytochemistry with functional context (GABAergic terminals), single lab","pmids":["14664820"],"is_preprint":false},{"year":2015,"finding":"GIRK3 in the ventral tegmental area (VTA) gates the mesolimbic dopaminergic response to ethanol; GIRK3 KO mice show blunted ethanol-induced VTA neuron excitation and reduced dopamine release in nucleus accumbens, and virally re-expressing GIRK3 specifically in VTA rescues this phenotype and decreases binge ethanol drinking.","method":"Conditional viral rescue in VTA, in vivo microdialysis (DA release), electrophysiology of VTA neurons in GIRK3 KO mice","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific viral rescue with multiple functional readouts (neuronal excitability, DA release, behavior)","pmids":["25964320"],"is_preprint":false},{"year":2009,"finding":"Kcnj9 (GIRK3) null mutant mice exhibit significantly less severe withdrawal from pentobarbital, zolpidem, and ethanol compared to wild-type littermates, establishing GIRK3 as a functional mediator of sedative-hypnotic withdrawal severity.","method":"Kcnj9-null mutant mouse model; behavioral assessment of withdrawal severity (QTL fine mapping to 0.44 Mb interval)","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with defined behavioral phenotype across multiple drug classes, single lab","pmids":["19759313"],"is_preprint":false},{"year":2008,"finding":"Kcnj9 (GIRK3) knockout mice show attenuated analgesic responses to opioid (morphine), α2-adrenergic (clonidine), and cannabinoid (WIN55,212-2) drugs, and differential Kcnj9 expression in periaqueductal gray of different inbred strains is driven by cis-acting genetic elements, placing GIRK3 in a shared downstream pathway for analgesia from multiple drug classes.","method":"Kcnj9 KO mouse thermal nociception assay; QTL mapping in F2 crosses; in silico haplotype analysis; midbrain PAG expression comparison","journal":"Pharmacogenetics and genomics","confidence":"Medium","confidence_rationale":"Tier 2 — KO with defined sensory phenotype across three drug classes, supported by QTL mapping, single lab","pmids":["18300945"],"is_preprint":false},{"year":2016,"finding":"The GIRK3 subunit is required for methamphetamine-induced attenuation of GABAB receptor-activated GIRK currents in VTA dopamine neurons; this effect depends on activation of both D1R-like and D2R-like receptors and does not involve dephosphorylation of GABABR2, distinguishing this plasticity mechanism from that in other reward neurons.","method":"Electrophysiology of VTA DA neurons from GIRK3 KO mice after repeated methamphetamine; pharmacological receptor blockade","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with defined electrophysiological phenotype and pharmacological dissection of mechanism, single lab","pmids":["26985023"],"is_preprint":false},{"year":2022,"finding":"GIRK3 deletion in chondrocytes increases their responsiveness to kappa opioid receptor (KOR) agonist dynorphin (greater pCREB, cAMP, GAG production, and upregulation of Col2a1 and Sox9), delays vascularization (reduced Kdr/Vegfr2 and endomucin expression), and promotes bone lengthening in mice.","method":"Girk3 KO mouse skeletal phenotyping; primary chondrocyte cultures and micromass assays; RNA-seq; KOR ligand stimulation assays; bone imaging","journal":"Bone","confidence":"Medium","confidence_rationale":"Tier 2 — KO with multiple cellular readouts and in vitro mechanistic follow-up, single lab","pmids":["35314385"],"is_preprint":false},{"year":2024,"finding":"GIRK3 deletion in osteoblasts/osteocytes (Col1a1-Cre) increases bone mass and strength in adult male mice; Girk3-/- bone marrow stromal cells are more proliferative and osteogenic, with altered Wnt pathway gene expression, and Wnt inhibition prevents the enhanced mineralization phenotype.","method":"Conditional KO using Col1a1-Cre; microCT, histomorphometry, in vitro osteoblast differentiation assays, Wnt inhibitor pharmacology","journal":"JBMR plus","confidence":"Medium","confidence_rationale":"Tier 2 — cell-type-specific KO with multiple functional readouts and pharmacological pathway dissection, single lab","pmids":["39228688"],"is_preprint":false},{"year":2008,"finding":"Kir3.3 protein is expressed specifically in supraependymal axons derived from dorsal raphe serotonergic neurons, while other Kir3 subfamily members and KATP subunits are absent, suggesting Kir3.3-containing channels may regulate autoregulation and excitability of these serotonergic fibers.","method":"Immunocytochemistry at light and electron microscopic levels in rodent brain","journal":"Neuroscience letters","confidence":"Low","confidence_rationale":"Tier 3 — single localization method without functional consequence directly measured","pmids":["18755244"],"is_preprint":false}],"current_model":"KCNJ9 (GIRK3/Kir3.3) is a G-protein-gated inwardly rectifying K+ channel subunit that co-assembles with GIRK1, GIRK2, or GIRK4 to form heterotetrameric channels activated by Gβγ; it mediates inhibitory opioid, GABAB, and other GPCR signals in neurons (including locus ceruleus, VTA dopamine neurons, and hippocampal interneurons), directly binds NCAM and TrkB to regulate surface expression and neurite outgrowth, forms pre-assembled signaling complexes with GABAB receptors at the ER/Golgi, and in non-neuronal contexts (chondrocytes, osteoblasts) controls GPCR-dependent bone growth and remodeling through Wnt and kappa opioid receptor pathways."},"narrative":{"teleology":[{"year":1999,"claim":"Establishing that GIRK3 forms functional heteromeric channels resolved whether this subunit contributes to Gβγ-gated K+ conductance or is an orphan subunit.","evidence":"Single-channel patch clamp of GIRK1/GIRK3 in CHO cells showing conductance, kinetics, and Gβγ sensitivity equivalent to other GIRK1 heteromers","pmids":["10341034"],"confidence":"Medium","gaps":["Only tested GIRK1/GIRK3 combination; native stoichiometry unknown","No in vivo validation"]},{"year":2000,"claim":"Demonstrating that GIRK2 and GIRK3 co-assemble without GIRK1 revealed an alternative channel composition with distinct Gβγ sensitivity, broadening the functional repertoire of GIRK signaling.","evidence":"Co-immunoprecipitation from transfected cells and native brain tissue; electrophysiology showing ~5-fold lower Gβγ sensitivity for GIRK2/GIRK3 versus GIRK1-containing channels","pmids":["10956667"],"confidence":"High","gaps":["Physiological contexts where GIRK2/GIRK3 operates preferentially over GIRK1-containing channels not defined","Structural basis for reduced Gβγ sensitivity unknown"]},{"year":2002,"claim":"Genetic ablation of GIRK2 and GIRK3 proved that these subunits form the principal channels mediating acute opioid inhibition in locus ceruleus neurons, overturning the view that cAMP-dependent conductances dominate.","evidence":"Whole-cell patch clamp in brain slices from single and double KO mice showing ~80% loss of opioid-induced current","pmids":["12040038"],"confidence":"High","gaps":["Relative contribution of GIRK3 alone versus GIRK2 not fully resolved in locus ceruleus","Downstream behavioral consequences of this specific current loss not tested"]},{"year":2003,"claim":"Identifying axonal sorting of GIRK3 in hippocampal GABAergic interneurons revealed a presynaptic role distinct from the predominantly somatodendritic localization of other GIRK subunits.","evidence":"Immunocytochemistry at light and electron microscopy levels in hippocampal CA3","pmids":["14664820"],"confidence":"Medium","gaps":["Functional consequence of presynaptic GIRK3 on GABA release not demonstrated","Mechanism of preferential axonal sorting unknown"]},{"year":2008,"claim":"KO studies across three analgesic drug classes (opioid, α2-adrenergic, cannabinoid) placed GIRK3 as a shared downstream effector for analgesia, and cis-regulatory variation in Kcnj9 expression was linked to strain differences in pain sensitivity.","evidence":"Kcnj9 KO mice tested in thermal nociception assays; QTL mapping and haplotype analysis in F2 crosses","pmids":["18300945"],"confidence":"Medium","gaps":["Cell types mediating GIRK3-dependent analgesia in periaqueductal gray not identified","Specific cis-regulatory element not mapped"]},{"year":2009,"claim":"Linking GIRK3 to sedative-hypnotic withdrawal severity across multiple drug classes (pentobarbital, zolpidem, ethanol) established a broader role for this channel in adaptive neural excitability beyond acute GPCR signaling.","evidence":"Kcnj9-null mice assessed for behavioral withdrawal severity with fine QTL mapping","pmids":["19759313"],"confidence":"Medium","gaps":["Circuit-level mechanism linking GIRK3 loss to reduced withdrawal not determined","Whether GIRK3 channel plasticity or expression changes mediate withdrawal severity unknown"]},{"year":2010,"claim":"Discovery that GABAB receptors form pre-assembled complexes with GIRK3-containing channels at the ER/Golgi showed that receptor-effector coupling is established during biosynthesis rather than solely at the plasma membrane.","evidence":"BRET, Co-IP, and electron microscopy in HEK-293 cells and native cerebellar granule cells","pmids":["20846323"],"confidence":"High","gaps":["Functional consequence of pre-assembly for signaling kinetics not quantified","Whether disruption of pre-assembly alters surface delivery unknown"]},{"year":2010,"claim":"Identification of direct NCAM and TrkB binding to the GIRK3 C-terminus connected ion channel trafficking to neurite outgrowth regulation, establishing GIRK3 as a node integrating neurotrophin and adhesion signaling.","evidence":"Co-IP, surface biotinylation, Xenopus oocyte electrophysiology, neurite outgrowth in hippocampal neurons, TrkB-deficient mouse validation","pmids":["20610389"],"confidence":"High","gaps":["Structural details of GIRK3–NCAM and GIRK3–TrkB interfaces unresolved","Whether this interaction occurs in adult brain or only during development not tested"]},{"year":2015,"claim":"Cell-type-specific viral rescue in VTA demonstrated that GIRK3 gates mesolimbic dopamine responses to ethanol, directly linking the channel to reward circuitry and binge drinking behavior.","evidence":"GIRK3 KO mice with viral re-expression in VTA; in vivo microdialysis for DA release; electrophysiology; ethanol drinking behavior","pmids":["25964320"],"confidence":"High","gaps":["Whether GIRK3 acts in GABA or dopamine neurons of VTA not fully resolved","Mechanism by which GIRK3 mediates ethanol-induced excitation (disinhibition vs. direct effect) unclear"]},{"year":2016,"claim":"Establishing GIRK3 as required for methamphetamine-induced attenuation of GABAB-GIRK currents in VTA DA neurons defined a subunit-specific plasticity mechanism distinct from GABABR2 dephosphorylation seen in other circuits.","evidence":"Electrophysiology in VTA DA neurons from GIRK3 KO mice after repeated methamphetamine; pharmacological dissection of D1R/D2R dependence","pmids":["26985023"],"confidence":"Medium","gaps":["Whether GIRK3 internalization, degradation, or altered subunit composition underlies the current reduction unknown","Single lab finding"]},{"year":2022,"claim":"Extending GIRK3 function beyond neurons, its deletion in chondrocytes enhanced kappa opioid receptor signaling and delayed vascularization, resulting in increased bone length—revealing a non-neuronal GPCR-effector role.","evidence":"Girk3 KO mouse skeletal phenotyping; chondrocyte micromass assays; RNA-seq; KOR ligand stimulation","pmids":["35314385"],"confidence":"Medium","gaps":["Whether GIRK3 forms conventional Gβγ-gated channels in chondrocytes or signals through an alternative mechanism not established","Single lab finding"]},{"year":2024,"claim":"Conditional deletion in osteoblasts/osteocytes showed GIRK3 constrains Wnt-dependent bone formation, establishing a second non-neuronal tissue where GIRK3 modulates GPCR-linked developmental signaling.","evidence":"Col1a1-Cre conditional KO; microCT, histomorphometry, in vitro osteoblast assays, Wnt inhibitor rescue","pmids":["39228688"],"confidence":"Medium","gaps":["Which specific Wnt ligand or receptor is regulated by GIRK3 unknown","Whether the osteoblast phenotype reflects channel activity or a non-conducting scaffolding role untested"]},{"year":null,"claim":"The structural basis for GIRK3's subunit-specific contributions—why it confers distinct Gβγ sensitivity, enables drug-induced plasticity, and scaffolds NCAM/TrkB—remains unresolved, as does whether its non-neuronal roles require ion conductance.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of GIRK3-containing heteromers available","Non-conducting versus conducting roles in bone cells not distinguished","Circuit identity of GIRK3-dependent VTA neurons (DA vs. GABA) not definitively resolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,2,6]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[3,4]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,4,6]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[3]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,5,6,9]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,4,8,10,11]}],"complexes":["GIRK1/GIRK3 heterotetramer","GIRK2/GIRK3 heterotetramer","GABAB-GIRK signaling complex"],"partners":["KCNJ3","KCNJ6","GABBR1","GABBR2","NCAM1","NTRK2"],"other_free_text":[]},"mechanistic_narrative":"KCNJ9 (GIRK3/Kir3.3) encodes an inwardly rectifying potassium channel subunit that co-assembles with GIRK1, GIRK2, or GIRK4 into Gβγ-activated heterotetrameric channels, serving as a principal effector of inhibitory GPCR signaling in the nervous system and peripheral tissues. GIRK2/GIRK3 heteromers display roughly 5-fold lower Gβγ sensitivity than GIRK1-containing channels, while GIRK1/GIRK3 channels are functionally equivalent to other GIRK1 heteromers; GIRK3-containing channels mediate opioid-induced hyperpolarization in locus ceruleus neurons and gate mesolimbic dopamine neuron responses in the VTA, where GIRK3 is required for methamphetamine-induced plasticity of GABAB-GIRK currents [PMID:12040038, PMID:10956667, PMID:25964320, PMID:26985023]. GIRK3 directly binds NCAM and TrkB via its C-terminal domain to regulate channel surface expression and neurite outgrowth, and forms pre-assembled signaling complexes with GABAB receptors at the ER/Golgi level [PMID:20610389, PMID:20846323]. In non-neuronal contexts, GIRK3 constrains kappa opioid receptor signaling in chondrocytes and Wnt-dependent osteoblast differentiation, such that its deletion increases bone length and mass [PMID:35314385, PMID:39228688]."},"prefetch_data":{"uniprot":{"accession":"Q92806","full_name":"G protein-activated inward rectifier potassium channel 3","aliases":["Inward rectifier K(+) channel Kir3.3","Potassium channel, inwardly rectifying subfamily J member 9"],"length_aa":393,"mass_kda":44.0,"function":"Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium, This receptor is controlled by G proteins. Unable to produce channel activity when expressed alone (PubMed:10659995). Forms a functional channel in association with KCNJ3/GIRK1 (By similarity)","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/Q92806/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KCNJ9","classification":"Not Classified","n_dependent_lines":137,"n_total_lines":1208,"dependency_fraction":0.11341059602649006},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KCNJ9","total_profiled":1310},"omim":[{"mim_id":"600932","title":"POTASSIUM INWARDLY-RECTIFYING CHANNEL, SUBFAMILY J, MEMBER 9; KCNJ9","url":"https://www.omim.org/entry/600932"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":69.4}],"url":"https://www.proteinatlas.org/search/KCNJ9"},"hgnc":{"alias_symbol":["Kir3.3","GIRK3"],"prev_symbol":[]},"alphafold":{"accession":"Q92806","domains":[{"cath_id":"1.10.287.70","chopping":"40-162","consensus_level":"high","plddt":93.5882,"start":40,"end":162},{"cath_id":"2.60.40.1400","chopping":"166-335","consensus_level":"high","plddt":94.2628,"start":166,"end":335}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92806","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q92806-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q92806-F1-predicted_aligned_error_v6.png","plddt_mean":85.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KCNJ9","jax_strain_url":"https://www.jax.org/strain/search?query=KCNJ9"},"sequence":{"accession":"Q92806","fasta_url":"https://rest.uniprot.org/uniprotkb/Q92806.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q92806/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92806"}},"corpus_meta":[{"pmid":"12040038","id":"PMC_12040038","title":"G-protein-gated potassium channels containing Kir3.2 and Kir3.3 subunits mediate the acute inhibitory effects of opioids on locus ceruleus neurons.","date":"2002","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12040038","citation_count":163,"is_preprint":false},{"pmid":"10956667","id":"PMC_10956667","title":"Functional and biochemical evidence for G-protein-gated inwardly rectifying K+ (GIRK) channels composed of GIRK2 and GIRK3.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10956667","citation_count":88,"is_preprint":false},{"pmid":"10341034","id":"PMC_10341034","title":"Functional expression and characterization of G-protein-gated inwardly rectifying K+ channels containing GIRK3.","date":"1999","source":"The Journal of membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/10341034","citation_count":50,"is_preprint":false},{"pmid":"25964320","id":"PMC_25964320","title":"GIRK3 gates activation of the mesolimbic dopaminergic pathway by ethanol.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25964320","citation_count":49,"is_preprint":false},{"pmid":"19759313","id":"PMC_19759313","title":"Mapping a barbiturate withdrawal locus to a 0.44 Mb interval and analysis of a novel null mutant identify a role for Kcnj9 (GIRK3) in withdrawal from pentobarbital, zolpidem, and ethanol.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19759313","citation_count":49,"is_preprint":false},{"pmid":"20846323","id":"PMC_20846323","title":"Evidence for oligomerization between GABAB receptors and GIRK channels containing the GIRK1 and GIRK3 subunits.","date":"2010","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20846323","citation_count":48,"is_preprint":false},{"pmid":"18300945","id":"PMC_18300945","title":"Quantitative trait locus and computational mapping identifies Kcnj9 (GIRK3) as a candidate gene affecting analgesia from multiple drug classes.","date":"2008","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/18300945","citation_count":46,"is_preprint":false},{"pmid":"26985023","id":"PMC_26985023","title":"A Role for the GIRK3 Subunit in Methamphetamine-Induced Attenuation of GABAB Receptor-Activated GIRK Currents in VTA Dopamine Neurons.","date":"2016","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26985023","citation_count":32,"is_preprint":false},{"pmid":"14664820","id":"PMC_14664820","title":"Axonal sorting of Kir3.3 defines a GABA-containing neuron in the CA3 region of rodent hippocampus.","date":"2003","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/14664820","citation_count":24,"is_preprint":false},{"pmid":"11350189","id":"PMC_11350189","title":"Analysis of linkage disequilibrium between polymorphisms in the KCNJ9 gene with type 2 diabetes mellitus in Pima Indians.","date":"2001","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/11350189","citation_count":20,"is_preprint":false},{"pmid":"20610389","id":"PMC_20610389","title":"Functional consequences of the interactions among the neural cell adhesion molecule NCAM, the receptor tyrosine kinase TrkB, and the inwardly rectifying K+ channel KIR3.3.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20610389","citation_count":20,"is_preprint":false},{"pmid":"10913335","id":"PMC_10913335","title":"Genomic structure and expression of human KCNJ9 (Kir3.3/GIRK3).","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10913335","citation_count":18,"is_preprint":false},{"pmid":"35314385","id":"PMC_35314385","title":"GIRK3 deletion facilitates kappa opioid signaling in chondrocytes, delays vascularization and promotes bone lengthening in mice.","date":"2022","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/35314385","citation_count":8,"is_preprint":false},{"pmid":"39228688","id":"PMC_39228688","title":"Girk3 deletion increases osteoblast maturation and bone mass accrual in adult male mice.","date":"2024","source":"JBMR plus","url":"https://pubmed.ncbi.nlm.nih.gov/39228688","citation_count":2,"is_preprint":false},{"pmid":"18755244","id":"PMC_18755244","title":"Expression of Kir3.3 potassium channel subunits in supraependymal axons.","date":"2008","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/18755244","citation_count":2,"is_preprint":false},{"pmid":"41084512","id":"PMC_41084512","title":"Global but not myeloid lineage-directed Girk3 deletion increases bone mass in female mice.","date":"2025","source":"JBMR plus","url":"https://pubmed.ncbi.nlm.nih.gov/41084512","citation_count":0,"is_preprint":false},{"pmid":"38798314","id":"PMC_38798314","title":"Atp1a2 and Kcnj9 are candidate genes underlying sensitivity to oxycodone-induced locomotor activation and withdrawal-induced anxiety-like behaviors in C57BL/6 substrains.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38798314","citation_count":0,"is_preprint":false},{"pmid":"36833293","id":"PMC_36833293","title":"De Novo Variant in the KCNJ9 Gene as a Possible Cause of Neonatal Seizures.","date":"2023","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36833293","citation_count":0,"is_preprint":false},{"pmid":"41490595","id":"PMC_41490595","title":"The circ-GLG1/miR-346/KCNJ9 axis drives malignant progression of bladder cancer by modulating KCNJ9 expression.","date":"2026","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/41490595","citation_count":0,"is_preprint":false},{"pmid":"39801366","id":"PMC_39801366","title":"Atp1a2 and Kcnj9 Are Candidate Genes Underlying Sensitivity to Oxycodone-Induced Locomotor Activation and Withdrawal-Induced Anxiety-Like Behaviors in C57BL/6 Substrains.","date":"2025","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/39801366","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":12119,"output_tokens":3296,"usd":0.042898},"stage2":{"model":"claude-opus-4-6","input_tokens":6695,"output_tokens":3130,"usd":0.167588},"total_usd":0.210486,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"GIRK channels containing Kir3.2 (GIRK2) and Kir3.3 (GIRK3) subunits mediate the acute inhibitory (hyperpolarizing) effects of opioids on locus ceruleus neurons; Kir3.2/3.3 double knockout mice showed ~80% reduction in opioid-induced current, demonstrating that K(G) channels—not cAMP-dependent cation conductance—are the primary mediators of this effect.\",\n      \"method\": \"Electrophysiology (whole-cell patch clamp) in brain slices from Kir3.2 KO, Kir3.3 KO, and Kir3.2/3.3 double KO mice with pharmacological blockers\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with defined electrophysiological phenotype, replicated across multiple genotypes with pharmacological validation\",\n      \"pmids\": [\"12040038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"GIRK2 and GIRK3 co-assemble into functional heteromultimeric GIRK channels; these channels display ~5-fold lower sensitivity to Gβγ activation compared to GIRK1-containing channels, and GIRK2/GIRK3 complexes can be immunoprecipitated from transfected cells and purified from native brain tissue.\",\n      \"method\": \"Patch clamp electrophysiology in co-transfected CHO-K1 cells; co-immunoprecipitation from transfected cells and native brain tissue\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP from both heterologous and native tissue plus functional characterization with multiple channel combinations\",\n      \"pmids\": [\"10956667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"GIRK3 forms functional heteromultimeric channels with GIRK1 (Kir3.1) in CHO cells; the GIRK1/GIRK3 combination has nearly identical single-channel conductance, kinetics, and Gβγ sensitivity compared to GIRK1/GIRK2 and GIRK1/GIRK4 channels.\",\n      \"method\": \"Single-channel patch clamp electrophysiology in CHO cells expressing GIRK1/GIRK3 with Gβγ dose-response\",\n      \"journal\": \"The Journal of membrane biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution in heterologous cells with single-channel analysis, single lab\",\n      \"pmids\": [\"10341034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"GABAB receptors form stable oligomeric complexes directly with GIRK channels containing GIRK3; BRET experiments in living cells showed direct interaction between GABAB receptors and GIRK1/GIRK3 heterotetramers, and these receptor-effector complexes also exist in vivo in cerebellar granule cells. Complex formation likely occurs in the ER/Golgi.\",\n      \"method\": \"Bioluminescence resonance energy transfer (BRET), co-immunoprecipitation, confocal and electron microscopy in HEK-293 cells and native brain tissue\",\n      \"journal\": \"The European journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (BRET, Co-IP, EM) in both heterologous and native tissue\",\n      \"pmids\": [\"20846323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Kir3.3 (GIRK3) directly binds NCAM and TrkB via its C-terminal intracellular domain; TrkB co-expression increases Kir3.1/3.3 K+ currents in Xenopus oocytes, while NCAM co-expression reduces this enhancement. TrkB regulates plasma membrane localization of Kir3.3, and premature Kir3.3 expression reduces NCAM-induced neurite outgrowth in hippocampal neurons.\",\n      \"method\": \"Co-immunoprecipitation, surface biotinylation, Xenopus oocyte electrophysiology, immunocytochemistry, analysis of TrkB-deficient mice, neurite outgrowth assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods across heterologous systems and primary neurons with genetic validation in KO mice\",\n      \"pmids\": [\"20610389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Kir3.3 (GIRK3) is sorted specifically to axons in a subset of large GABAergic interneurons in the hippocampal CA3 region, with high levels in axons running with the mossy fiber tract and in large synaptic terminals co-expressing the vesicular GABA transporter.\",\n      \"method\": \"Immunocytochemistry (light and electron microscopy), primary cultures from hippocampal subareas in rodent brain\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct subcellular localization by immunocytochemistry with functional context (GABAergic terminals), single lab\",\n      \"pmids\": [\"14664820\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GIRK3 in the ventral tegmental area (VTA) gates the mesolimbic dopaminergic response to ethanol; GIRK3 KO mice show blunted ethanol-induced VTA neuron excitation and reduced dopamine release in nucleus accumbens, and virally re-expressing GIRK3 specifically in VTA rescues this phenotype and decreases binge ethanol drinking.\",\n      \"method\": \"Conditional viral rescue in VTA, in vivo microdialysis (DA release), electrophysiology of VTA neurons in GIRK3 KO mice\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific viral rescue with multiple functional readouts (neuronal excitability, DA release, behavior)\",\n      \"pmids\": [\"25964320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Kcnj9 (GIRK3) null mutant mice exhibit significantly less severe withdrawal from pentobarbital, zolpidem, and ethanol compared to wild-type littermates, establishing GIRK3 as a functional mediator of sedative-hypnotic withdrawal severity.\",\n      \"method\": \"Kcnj9-null mutant mouse model; behavioral assessment of withdrawal severity (QTL fine mapping to 0.44 Mb interval)\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined behavioral phenotype across multiple drug classes, single lab\",\n      \"pmids\": [\"19759313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Kcnj9 (GIRK3) knockout mice show attenuated analgesic responses to opioid (morphine), α2-adrenergic (clonidine), and cannabinoid (WIN55,212-2) drugs, and differential Kcnj9 expression in periaqueductal gray of different inbred strains is driven by cis-acting genetic elements, placing GIRK3 in a shared downstream pathway for analgesia from multiple drug classes.\",\n      \"method\": \"Kcnj9 KO mouse thermal nociception assay; QTL mapping in F2 crosses; in silico haplotype analysis; midbrain PAG expression comparison\",\n      \"journal\": \"Pharmacogenetics and genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined sensory phenotype across three drug classes, supported by QTL mapping, single lab\",\n      \"pmids\": [\"18300945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The GIRK3 subunit is required for methamphetamine-induced attenuation of GABAB receptor-activated GIRK currents in VTA dopamine neurons; this effect depends on activation of both D1R-like and D2R-like receptors and does not involve dephosphorylation of GABABR2, distinguishing this plasticity mechanism from that in other reward neurons.\",\n      \"method\": \"Electrophysiology of VTA DA neurons from GIRK3 KO mice after repeated methamphetamine; pharmacological receptor blockade\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined electrophysiological phenotype and pharmacological dissection of mechanism, single lab\",\n      \"pmids\": [\"26985023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GIRK3 deletion in chondrocytes increases their responsiveness to kappa opioid receptor (KOR) agonist dynorphin (greater pCREB, cAMP, GAG production, and upregulation of Col2a1 and Sox9), delays vascularization (reduced Kdr/Vegfr2 and endomucin expression), and promotes bone lengthening in mice.\",\n      \"method\": \"Girk3 KO mouse skeletal phenotyping; primary chondrocyte cultures and micromass assays; RNA-seq; KOR ligand stimulation assays; bone imaging\",\n      \"journal\": \"Bone\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with multiple cellular readouts and in vitro mechanistic follow-up, single lab\",\n      \"pmids\": [\"35314385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GIRK3 deletion in osteoblasts/osteocytes (Col1a1-Cre) increases bone mass and strength in adult male mice; Girk3-/- bone marrow stromal cells are more proliferative and osteogenic, with altered Wnt pathway gene expression, and Wnt inhibition prevents the enhanced mineralization phenotype.\",\n      \"method\": \"Conditional KO using Col1a1-Cre; microCT, histomorphometry, in vitro osteoblast differentiation assays, Wnt inhibitor pharmacology\",\n      \"journal\": \"JBMR plus\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific KO with multiple functional readouts and pharmacological pathway dissection, single lab\",\n      \"pmids\": [\"39228688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Kir3.3 protein is expressed specifically in supraependymal axons derived from dorsal raphe serotonergic neurons, while other Kir3 subfamily members and KATP subunits are absent, suggesting Kir3.3-containing channels may regulate autoregulation and excitability of these serotonergic fibers.\",\n      \"method\": \"Immunocytochemistry at light and electron microscopic levels in rodent brain\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single localization method without functional consequence directly measured\",\n      \"pmids\": [\"18755244\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KCNJ9 (GIRK3/Kir3.3) is a G-protein-gated inwardly rectifying K+ channel subunit that co-assembles with GIRK1, GIRK2, or GIRK4 to form heterotetrameric channels activated by Gβγ; it mediates inhibitory opioid, GABAB, and other GPCR signals in neurons (including locus ceruleus, VTA dopamine neurons, and hippocampal interneurons), directly binds NCAM and TrkB to regulate surface expression and neurite outgrowth, forms pre-assembled signaling complexes with GABAB receptors at the ER/Golgi, and in non-neuronal contexts (chondrocytes, osteoblasts) controls GPCR-dependent bone growth and remodeling through Wnt and kappa opioid receptor pathways.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"KCNJ9 (GIRK3/Kir3.3) encodes an inwardly rectifying potassium channel subunit that co-assembles with GIRK1, GIRK2, or GIRK4 into Gβγ-activated heterotetrameric channels, serving as a principal effector of inhibitory GPCR signaling in the nervous system and peripheral tissues. GIRK2/GIRK3 heteromers display roughly 5-fold lower Gβγ sensitivity than GIRK1-containing channels, while GIRK1/GIRK3 channels are functionally equivalent to other GIRK1 heteromers; GIRK3-containing channels mediate opioid-induced hyperpolarization in locus ceruleus neurons and gate mesolimbic dopamine neuron responses in the VTA, where GIRK3 is required for methamphetamine-induced plasticity of GABAB-GIRK currents [PMID:12040038, PMID:10956667, PMID:25964320, PMID:26985023]. GIRK3 directly binds NCAM and TrkB via its C-terminal domain to regulate channel surface expression and neurite outgrowth, and forms pre-assembled signaling complexes with GABAB receptors at the ER/Golgi level [PMID:20610389, PMID:20846323]. In non-neuronal contexts, GIRK3 constrains kappa opioid receptor signaling in chondrocytes and Wnt-dependent osteoblast differentiation, such that its deletion increases bone length and mass [PMID:35314385, PMID:39228688].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing that GIRK3 forms functional heteromeric channels resolved whether this subunit contributes to Gβγ-gated K+ conductance or is an orphan subunit.\",\n      \"evidence\": \"Single-channel patch clamp of GIRK1/GIRK3 in CHO cells showing conductance, kinetics, and Gβγ sensitivity equivalent to other GIRK1 heteromers\",\n      \"pmids\": [\"10341034\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Only tested GIRK1/GIRK3 combination; native stoichiometry unknown\", \"No in vivo validation\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrating that GIRK2 and GIRK3 co-assemble without GIRK1 revealed an alternative channel composition with distinct Gβγ sensitivity, broadening the functional repertoire of GIRK signaling.\",\n      \"evidence\": \"Co-immunoprecipitation from transfected cells and native brain tissue; electrophysiology showing ~5-fold lower Gβγ sensitivity for GIRK2/GIRK3 versus GIRK1-containing channels\",\n      \"pmids\": [\"10956667\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological contexts where GIRK2/GIRK3 operates preferentially over GIRK1-containing channels not defined\", \"Structural basis for reduced Gβγ sensitivity unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Genetic ablation of GIRK2 and GIRK3 proved that these subunits form the principal channels mediating acute opioid inhibition in locus ceruleus neurons, overturning the view that cAMP-dependent conductances dominate.\",\n      \"evidence\": \"Whole-cell patch clamp in brain slices from single and double KO mice showing ~80% loss of opioid-induced current\",\n      \"pmids\": [\"12040038\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of GIRK3 alone versus GIRK2 not fully resolved in locus ceruleus\", \"Downstream behavioral consequences of this specific current loss not tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identifying axonal sorting of GIRK3 in hippocampal GABAergic interneurons revealed a presynaptic role distinct from the predominantly somatodendritic localization of other GIRK subunits.\",\n      \"evidence\": \"Immunocytochemistry at light and electron microscopy levels in hippocampal CA3\",\n      \"pmids\": [\"14664820\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of presynaptic GIRK3 on GABA release not demonstrated\", \"Mechanism of preferential axonal sorting unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"KO studies across three analgesic drug classes (opioid, α2-adrenergic, cannabinoid) placed GIRK3 as a shared downstream effector for analgesia, and cis-regulatory variation in Kcnj9 expression was linked to strain differences in pain sensitivity.\",\n      \"evidence\": \"Kcnj9 KO mice tested in thermal nociception assays; QTL mapping and haplotype analysis in F2 crosses\",\n      \"pmids\": [\"18300945\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cell types mediating GIRK3-dependent analgesia in periaqueductal gray not identified\", \"Specific cis-regulatory element not mapped\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Linking GIRK3 to sedative-hypnotic withdrawal severity across multiple drug classes (pentobarbital, zolpidem, ethanol) established a broader role for this channel in adaptive neural excitability beyond acute GPCR signaling.\",\n      \"evidence\": \"Kcnj9-null mice assessed for behavioral withdrawal severity with fine QTL mapping\",\n      \"pmids\": [\"19759313\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Circuit-level mechanism linking GIRK3 loss to reduced withdrawal not determined\", \"Whether GIRK3 channel plasticity or expression changes mediate withdrawal severity unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Discovery that GABAB receptors form pre-assembled complexes with GIRK3-containing channels at the ER/Golgi showed that receptor-effector coupling is established during biosynthesis rather than solely at the plasma membrane.\",\n      \"evidence\": \"BRET, Co-IP, and electron microscopy in HEK-293 cells and native cerebellar granule cells\",\n      \"pmids\": [\"20846323\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of pre-assembly for signaling kinetics not quantified\", \"Whether disruption of pre-assembly alters surface delivery unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identification of direct NCAM and TrkB binding to the GIRK3 C-terminus connected ion channel trafficking to neurite outgrowth regulation, establishing GIRK3 as a node integrating neurotrophin and adhesion signaling.\",\n      \"evidence\": \"Co-IP, surface biotinylation, Xenopus oocyte electrophysiology, neurite outgrowth in hippocampal neurons, TrkB-deficient mouse validation\",\n      \"pmids\": [\"20610389\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural details of GIRK3–NCAM and GIRK3–TrkB interfaces unresolved\", \"Whether this interaction occurs in adult brain or only during development not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Cell-type-specific viral rescue in VTA demonstrated that GIRK3 gates mesolimbic dopamine responses to ethanol, directly linking the channel to reward circuitry and binge drinking behavior.\",\n      \"evidence\": \"GIRK3 KO mice with viral re-expression in VTA; in vivo microdialysis for DA release; electrophysiology; ethanol drinking behavior\",\n      \"pmids\": [\"25964320\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GIRK3 acts in GABA or dopamine neurons of VTA not fully resolved\", \"Mechanism by which GIRK3 mediates ethanol-induced excitation (disinhibition vs. direct effect) unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Establishing GIRK3 as required for methamphetamine-induced attenuation of GABAB-GIRK currents in VTA DA neurons defined a subunit-specific plasticity mechanism distinct from GABABR2 dephosphorylation seen in other circuits.\",\n      \"evidence\": \"Electrophysiology in VTA DA neurons from GIRK3 KO mice after repeated methamphetamine; pharmacological dissection of D1R/D2R dependence\",\n      \"pmids\": [\"26985023\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether GIRK3 internalization, degradation, or altered subunit composition underlies the current reduction unknown\", \"Single lab finding\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extending GIRK3 function beyond neurons, its deletion in chondrocytes enhanced kappa opioid receptor signaling and delayed vascularization, resulting in increased bone length—revealing a non-neuronal GPCR-effector role.\",\n      \"evidence\": \"Girk3 KO mouse skeletal phenotyping; chondrocyte micromass assays; RNA-seq; KOR ligand stimulation\",\n      \"pmids\": [\"35314385\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether GIRK3 forms conventional Gβγ-gated channels in chondrocytes or signals through an alternative mechanism not established\", \"Single lab finding\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Conditional deletion in osteoblasts/osteocytes showed GIRK3 constrains Wnt-dependent bone formation, establishing a second non-neuronal tissue where GIRK3 modulates GPCR-linked developmental signaling.\",\n      \"evidence\": \"Col1a1-Cre conditional KO; microCT, histomorphometry, in vitro osteoblast assays, Wnt inhibitor rescue\",\n      \"pmids\": [\"39228688\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Which specific Wnt ligand or receptor is regulated by GIRK3 unknown\", \"Whether the osteoblast phenotype reflects channel activity or a non-conducting scaffolding role untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis for GIRK3's subunit-specific contributions—why it confers distinct Gβγ sensitivity, enables drug-induced plasticity, and scaffolds NCAM/TrkB—remains unresolved, as does whether its non-neuronal roles require ion conductance.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of GIRK3-containing heteromers available\", \"Non-conducting versus conducting roles in bone cells not distinguished\", \"Circuit identity of GIRK3-dependent VTA neurons (DA vs. GABA) not definitively resolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 2, 6]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [3, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 4, 6]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 5, 6, 9]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 4, 8, 10, 11]}\n    ],\n    \"complexes\": [\n      \"GIRK1/GIRK3 heterotetramer\",\n      \"GIRK2/GIRK3 heterotetramer\",\n      \"GABAB-GIRK signaling complex\"\n    ],\n    \"partners\": [\n      \"KCNJ3\",\n      \"KCNJ6\",\n      \"GABBR1\",\n      \"GABBR2\",\n      \"NCAM1\",\n      \"NTRK2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}